Home Health Care News July 28, 2022
When it comes to home health providers, it’s safe to say that the proposed payment rule is the talk of the town.
And Amedisys Inc. (Nasdaq: AMED) is no exception.
“The topic on everyone’s mind has been the proposed home health rule for 2023,” Amedisys CEO Chris Gerard said during the company’s second quarter earnings call Thursday.
The U.S. Centers for Medicare & Medicaid Services (CMS) released its proposal for home health care last month. Since its release, the proposed rule had garnered a severely negative reaction from home health stakeholders.
Amedisys took aim at the proposed rule’s 4.2% reduction to home health payment rates.
“The methodology and data that CMS is using is woefully inadequate to capture the true...
Today's Sponsors
Today's Sponsor